23/48
2.4 / 5 stars
All 48 Win/Lose results and 72 gray no-data contests shown below
APYX Roast Me summary
Apyx Medical Corp (APYX). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth No data.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth No data.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth No data.
Trailing 1 year (4 quarters): 6 wins, 2 losses, 4 no dataLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/2 |
WinAPYX / S&P 21.68% / 15.20% |
WinAPYX / S&P 25.59% / 15.00% |
No dataAPYX / S&P / 50.40% |
| 2026-Q12/2 |
WinAPYX / S&P 5.43% / -4.33% |
WinAPYX / S&P 18.22% / 11.30% |
No dataAPYX / S&P / 27.70% |
| 2025-Q42/2 |
WinAPYX / S&P 63.55% / 2.65% |
WinAPYX / S&P 9.86% / 9.00% |
No dataAPYX / S&P / 13.40% |
| 2025-Q30/2 |
LoseAPYX / S&P -4.89% / 8.12% |
LoseAPYX / S&P -1.32% / 4.61% |
No dataAPYX / S&P / 13.45% |
| 2025-Q21/2 |
WinAPYX / S&P 64.23% / 10.94% |
LoseAPYX / S&P -5.14% / 4.83% |
No dataAPYX / S&P / 10.63% |
| 2025-Q10/1 |
LoseAPYX / S&P -13.29% / -4.27% |
No dataAPYX / S&P / 4.98% |
No dataAPYX / S&P / 10.57% |
| 2024-Q41/2 |
WinAPYX / S&P 27.42% / 2.41% |
LoseAPYX / S&P -8.11% / 5.25% |
No dataAPYX / S&P / 6.15% |
| 2024-Q30/1 |
LoseAPYX / S&P -7.46% / 5.89% |
No dataAPYX / S&P / 5.89% |
No dataAPYX / S&P / 6.11% |
| 2024-Q20/1 |
LoseAPYX / S&P -1.47% / 4.28% |
No dataAPYX / S&P / 5.38% |
No dataAPYX / S&P / 5.12% |
| 2024-Q10/1 |
LoseAPYX / S&P -48.09% / 10.56% |
No dataAPYX / S&P / 5.71% |
No dataAPYX / S&P / 5.59% |
| 2023-Q40/1 |
LoseAPYX / S&P -18.13% / 11.69% |
No dataAPYX / S&P / 6.81% |
No dataAPYX / S&P / 7.78% |
| 2023-Q30/1 |
LoseAPYX / S&P -36.38% / -3.27% |
No dataAPYX / S&P / 7.52% |
No dataAPYX / S&P / -5.03% |
| 2023-Q21/1 |
WinAPYX / S&P 74.65% / 8.74% |
No dataAPYX / S&P / 9.50% |
No dataAPYX / S&P / -8.57% |
| 2023-Q11/1 |
WinAPYX / S&P 23.08% / 7.50% |
No dataAPYX / S&P / 10.77% |
No dataAPYX / S&P / -15.69% |
| 2022-Q40/1 |
LoseAPYX / S&P -47.88% / 7.56% |
No dataAPYX / S&P / 11.88% |
No dataAPYX / S&P / -17.99% |
| 2022-Q30/1 |
LoseAPYX / S&P -23.38% / -4.88% |
No dataAPYX / S&P / 13.47% |
No dataAPYX / S&P / -1.41% |
| 2022-Q21/1 |
WinAPYX / S&P -10.26% / -16.10% |
No dataAPYX / S&P / 13.71% |
No dataAPYX / S&P / 11.04% |
| 2022-Q10/1 |
LoseAPYX / S&P -49.06% / -4.60% |
No dataAPYX / S&P / 15.97% |
No dataAPYX / S&P / 42.23% |
| 2021-Q40/1 |
LoseAPYX / S&P -7.44% / 11.03% |
No dataAPYX / S&P / 15.00% |
No dataAPYX / S&P / 96.40% |
| 2021-Q31/1 |
WinAPYX / S&P 34.34% / 0.58% |
No dataAPYX / S&P / 10.77% |
No dataAPYX / S&P / 69.42% |
| 2021-Q20/1 |
LoseAPYX / S&P 6.73% / 8.55% |
No dataAPYX / S&P / 6.58% |
No dataAPYX / S&P / 51.81% |
| 2021-Q11/1 |
WinAPYX / S&P 34.17% / 6.17% |
No dataAPYX / S&P / -1.06% |
No dataAPYX / S&P / 7.39% |
| 2020-Q41/1 |
WinAPYX / S&P 52.87% / 12.15% |
No dataAPYX / S&P / -3.72% |
No dataAPYX / S&P / -33.42% |
| 2020-Q30/1 |
LoseAPYX / S&P -15.14% / 8.93% |
No dataAPYX / S&P / -2.04% |
No dataAPYX / S&P / -27.10% |
| 2020-Q21/1 |
WinAPYX / S&P 54.60% / 20.54% |
No dataAPYX / S&P / -0.46% |
No dataAPYX / S&P / -27.11% |
| 2020-Q10/1 |
LoseAPYX / S&P -57.57% / -19.60% |
No dataAPYX / S&P / 3.47% |
No dataAPYX / S&P / -14.75% |
| 2019-Q41/2 |
WinAPYX / S&P 24.96% / 9.07% |
No dataAPYX / S&P / 5.36% |
LoseAPYX / S&P -131.69% / 2.99% |
| 2019-Q30/1 |
LoseAPYX / S&P 0.74% / 1.70% |
No dataAPYX / S&P / 5.02% |
No dataAPYX / S&P / 0.21% |
| 2019-Q21/1 |
WinAPYX / S&P 6.50% / 4.30% |
No dataAPYX / S&P / 6.64% |
No dataAPYX / S&P / 8.65% |
| 2019-Q10/0 |
No dataAPYX / S&P / 13.65% |
No dataAPYX / S&P / 8.12% |
No dataAPYX / S&P / 14.29% |
| 2018-Q41/1 |
No dataAPYX / S&P / -13.52% |
WinAPYX / S&P 63.04% / 9.05% |
No dataAPYX / S&P / 18.23% |
| 2018-Q31/1 |
No dataAPYX / S&P / 7.71% |
WinAPYX / S&P 1037.47% / 10.21% |
No dataAPYX / S&P / 19.06% |
| 2018-Q21/1 |
No dataAPYX / S&P / 3.43% |
WinAPYX / S&P 178.76% / 9.03% |
No dataAPYX / S&P / 14.46% |
| 2018-Q11/1 |
No dataAPYX / S&P / -0.76% |
WinAPYX / S&P 175.88% / 7.68% |
No dataAPYX / S&P / 12.46% |
| 2017-Q41/1 |
No dataAPYX / S&P / 6.64% |
WinAPYX / S&P 16.04% / 7.03% |
No dataAPYX / S&P / 13.82% |
| 2017-Q30/1 |
No dataAPYX / S&P / 4.48% |
LoseAPYX / S&P -92.87% / 5.68% |
No dataAPYX / S&P / 17.57% |
| 2017-Q20/1 |
No dataAPYX / S&P / 3.09% |
LoseAPYX / S&P -70.06% / 4.83% |
No dataAPYX / S&P / 17.74% |
| 2017-Q10/1 |
No dataAPYX / S&P / 6.07% |
LoseAPYX / S&P -69.73% / 3.67% |
No dataAPYX / S&P / 13.32% |
| 2016-Q40/2 |
No dataAPYX / S&P / 3.82% |
LoseAPYX / S&P -70.13% / 2.09% |
LoseAPYX / S&P -162.50% / 7.05% |
| 2016-Q31/2 |
No dataAPYX / S&P / 3.85% |
WinAPYX / S&P 23.47% / 0.20% |
LoseAPYX / S&P -242.86% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | APYX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 54.78% | 20.78% |
| Annualized return | 54.78% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | APYX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.57% | 83.14% |
| Annualized return | -22.80% | 12.86% |
10Y · 2019-01-02 to 2026-08-28
| Metric | APYX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -52.39% | 319.30% |
| Annualized return | -7.15% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |